Trials / Completed
CompletedNCT05592548
Rosacea Treatment Using Non-thermal (Cold) Atmospheric Plasma Device
Open Label Split Face Pilot Study to Assess the Safety and Efficacy of Cold Atmospheric Plasma (Non-thermal Plasma) for the Treatment of Rosacea
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- The Skin Center Dermatology Group · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
10-13 patients will be enrolled to receive split face treatment: the control side will be treated with metronidazole cream, the intervention side will be treated with a cold atmospheric plasma device
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | cold atmospheric plasma | Cold atmospheric plasma will be generated on the skin surface using an electric device |
Timeline
- Start date
- 2024-01-02
- Primary completion
- 2024-05-31
- Completion
- 2024-06-30
- First posted
- 2022-10-24
- Last updated
- 2024-12-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05592548. Inclusion in this directory is not an endorsement.